Biotalys Announces Changes to its Board of Directors and Executive Committee

Core Insights - Biotalys, an AgTech company focused on protein-based biocontrol solutions for sustainable crop protection, announced significant changes to its board and management team, reducing the Board of Directors from eight to six members and the Executive Committee from four to two members [1][2]. Management Changes - Laura Meyer has stepped down as a board member and Chair of the Audit Committee effective immediately [2]. - CEO Kevin Helash and Chief Business Development Officer Kamal El Mernissi will also leave the company, with Helash departing immediately and El Mernissi's departure effective March 31, 2026 [2][3]. - Patrik Haesen has been appointed as Chair of the Audit Committee, while Carlo Boutton will serve as interim CEO [2]. Company Background - Biotalys specializes in developing precision biocontrol solutions based on proteins for crop protection in both pre- and post-harvest markets [5]. - The company utilizes its AGROBODY™ technology platform to create a diverse pipeline of product candidates aimed at addressing key crop pests and diseases [5]. - Founded in 2013 as a spin-off from the VIB (Flanders Institute for Biotechnology), Biotalys is based in Ghent, Belgium, and is listed on Euronext Brussels [5].